Boswellia: Benefits, Dosage, Best Forms & Safety

What Is Boswellia?

Boswellia (Boswellia serrata), also known as Indian frankincense, is a tree resin that has been used for centuries in Ayurvedic medicine for inflammatory conditions. Its key active compounds, boswellic acids, particularly a form called AKBA (acetyl-11-keto-beta-boswellic acid), are believed to inhibit 5-lipoxygenase, an enzyme involved in producing inflammatory compounds called leukotrienes.

This mechanism is distinct from how NSAIDs (like ibuprofen) work, which primarily target a different inflammatory pathway (COX enzymes). This is part of why boswellia is often studied and used as a complementary option alongside, or as an alternative for people who cannot tolerate, standard anti-inflammatory medications.

Evidence-Based Benefits

• Osteoarthritis pain and function. Multiple randomized, placebo-controlled trials, particularly using extracts standardized for AKBA content, show meaningful reductions in knee pain and improvements in physical function, with some trials showing effects within just 5-7 days of starting.
• Inflammatory bowel conditions. Some trials in ulcerative colitis suggest boswellia extract may help maintain remission comparably to standard treatment in certain patients, though it should be used alongside, not instead of, prescribed IBD treatment.
• General inflammatory markers. Laboratory and some human studies show boswellic acids reduce markers of inflammation, consistent with its traditional anti-inflammatory use and its distinct 5-lipoxygenase inhibition mechanism.
• Asthma and respiratory symptoms. A smaller number of trials suggest boswellia may modestly reduce asthma symptoms and inflammatory markers in the airways, an area of less extensive but ongoing research.

Best Forms to Buy

• Standardized extract (high AKBA content): The form used in most positive osteoarthritis trials; look for a stated percentage of boswellic acids or specifically AKBA on the label, since AKBA content varies significantly between raw resin and processed extracts.
• Raw resin / whole extract: Contains a broader mix of boswellic acids but less standardized dose-to-dose than concentrated extracts, making trial-level dosing harder to replicate.

Dosage Guide

• Standard Dose: 100-250 mg per day of a standardized extract (often labeled for its AKBA percentage) for joint comfort, based on the doses most commonly used in positive clinical trials; some studies use higher total resin extract doses of 300-500 mg two to three times daily.
• Upper Limit (UL): No official UL has been established by NIH ODS; most clinical trials run 8-12 weeks, so long-term (multi-year) daily-use safety data is more limited than for well-established minerals.
• Timing: Typically taken with food to reduce the chance of mild stomach upset; some trials report noticeable effects within one to two weeks.
• Notes: For a full breakdown of boswellia dosing specifically for joint comfort, see our related article, Boswellia Serrata Dosing and Safety: What the Research Actually Shows.

Drug & Supplement Interactions

• NSAIDs and other anti-inflammatory drugs (Low): Boswellia works through a different inflammatory pathway than NSAIDs, so combining them is generally considered lower risk than combining two NSAIDs, though additive stomach upset is possible.
• Anticoagulants and antiplatelet drugs (Medium): Some evidence suggests boswellic acids may have mild antiplatelet activity, which could theoretically increase bleeding risk when combined with warfarin, aspirin, or other blood thinners.
• Chemotherapy drugs (Low): Boswellia is being researched for its own anti-inflammatory and potential anti-tumor properties in some contexts; anyone in active cancer treatment should discuss any supplement, including boswellia, with their oncology team.
• Diabetes medication (Low): Limited evidence suggests boswellia may have a mild effect on blood sugar; monitor glucose if combined with insulin or oral diabetes medications.

Safety & Side Effects

Boswellia is generally well tolerated in clinical trials, with mild gastrointestinal symptoms like nausea, acid reflux, or diarrhea being the most commonly reported side effects.

Because of its potential mild effect on platelet function, people on blood thinners or with a scheduled surgery should discuss boswellia use with their doctor beforehand, and safety data in pregnancy is limited, so it should be avoided unless a doctor advises otherwise.

Bottom Line

Boswellia has one of the more consistent clinical trial records among joint-support botanicals, with a genuinely distinct anti-inflammatory mechanism from NSAIDs that makes it a reasonable complementary option for people with osteoarthritis. Choosing a standardized, AKBA-verified extract matters for matching the results seen in clinical research.

Frequently Asked Questions

Q: How fast does boswellia work for joint pain?
A: Some clinical trials report noticeable improvement within 5-7 days, faster than some other joint-support ingredients, though consistent use over several weeks is typically studied for full effect.

Q: Is boswellia the same as frankincense?
A: Yes, boswellia resin is the source of frankincense; the supplement extracts are standardized specifically for their boswellic acid content, which is different from frankincense essential oil used aromatically.

Q: Can I take boswellia with ibuprofen or other NSAIDs?
A: Generally considered lower risk than combining two NSAIDs since the mechanisms differ, but it’s still worth mentioning to your doctor, especially with regular NSAID use.

Q: Does boswellia interact with blood thinners?
A: It may have mild antiplatelet activity, so combining it with warfarin, aspirin, or other blood thinners should be discussed with a doctor.

Sources

• NCCIH: general herbal anti-inflammatory supplement safety guidance
• Cochrane-indexed randomized trials on Boswellia serrata extract for osteoarthritis
• Mayo Clinic: Boswellia Overview
• Phytomedicine (journal): boswellic acid mechanism and clinical trial reviews
• Cleveland Clinic, Boswellia: Benefits and Side Effects